{
    "clinical_study": {
        "@rank": "41710", 
        "arm_group": [
            {
                "arm_group_label": "Group A", 
                "description": "Subjects in this group will be all physicians actively working at hospital centres in Spain."
            }, 
            {
                "arm_group_label": "Group B", 
                "description": "Subjects in this group will be all nurses actively working at hospital centres in Spain."
            }, 
            {
                "arm_group_label": "Group C", 
                "description": "Subjects in this group will be all ancillary nursing professionals actively working at hospital centres in Spain."
            }, 
            {
                "arm_group_label": "Group D", 
                "description": "Subjects in this group will be all midwives actively working at hospital centres in Spain."
            }
        ], 
        "biospec_descr": {
            "textblock": "Blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This study aims to determine the sero-prevalence of anti-pertussis antibodies among\n      healthcare professionals at hospital centres in Spain."
        }, 
        "brief_title": "Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Pertussis", 
        "condition_browse": {
            "mesh_term": "Whooping Cough"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Written informed consent obtained from the subject.\n\n          -  Subjects who the investigator believes that they can and will comply with the\n             requirements of the protocol.\n\n          -  Male and female healthcare professionals aged \u226518 years from selected hospitals.\n\n          -  Healthcare professionals in frequent contact with patients in the hospitals.\n\n          -  Agreeing for collection of a blood sample for the study.\n\n        Exclusion Criteria:\n\n        \u2022  Medical students working as healthcare professionals."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Healthcare professionals actively working and involved with patient care in Spanish\n        hospitals."
            }
        }, 
        "enrollment": {
            "#text": "757", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01706224", 
            "org_study_id": "115539"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Group C", 
                    "Group B", 
                    "Group A", 
                    "Group D"
                ], 
                "description": "Samples will be tested to determine the presence of anti-pertussis antibodies.", 
                "intervention_name": "Blood sample", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "Group C", 
                    "Group B", 
                    "Group A", 
                    "Group D"
                ], 
                "description": "Electronic Case Report Forms (eCRF)", 
                "intervention_name": "Data collection", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Group C", 
                    "Group B", 
                    "Group A", 
                    "Group D"
                ], 
                "description": "Questionnaires, active questioning.", 
                "intervention_name": "Data collection", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antibodies", 
                "Immunoglobulins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pertussis antibodies", 
            "Bordetella pertussis", 
            "sero-prevalence", 
            "Healthcare professionals (HCP)", 
            "Spain"
        ], 
        "lastchanged_date": "January 9, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Hospitalet de Llobregat", 
                        "country": "Spain", 
                        "zip": "08907"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Coru\u00f1a", 
                        "country": "Spain", 
                        "zip": "15006"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Majadahonda", 
                        "country": "Spain"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "4", 
        "official_title": "Sero-prevalence of Pertussis Antibodies and Disease Awareness Among Healthcare Professionals in Spain", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Evaluation of the overall sero-prevalence of Bordetella pertussis infection among subjects with respect to anti-pertussis (anti-PT) antibody levels.", 
                "safety_issue": "No", 
                "time_frame": "Day 0 of each subject at the time of enrollment."
            }, 
            {
                "measure": "Evaluation of the overall sero-prevalence of Bordetella pertussis infection among subjects with respect to anti-PT seropositivity status.", 
                "safety_issue": "No", 
                "time_frame": "Day 0 of each subject at the time of enrollment."
            }, 
            {
                "measure": "Evaluation of the overall sero-prevalence of Bordetella pertussis infection among subjects with respect to anti-PT seronegativity status.", 
                "safety_issue": "No", 
                "time_frame": "Day 0 of each subject at the time of enrollment."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01706224"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "By age and gender, by type of healthcare professional, by hospital department of the healthcare professional, duration of service and time spent with patients.", 
                "measure": "Evaluation of the sero-prevalence of B. pertussis antibodies among healthcare professionals aged \u2265 18 years.", 
                "safety_issue": "No", 
                "time_frame": "Day 0 of each subject at the time of enrollment."
            }, 
            {
                "measure": "Evaluation of the sero-prevalence of anti-pertussis antibodies among healthcare professionals by vaccination history.", 
                "safety_issue": "No", 
                "time_frame": "Day 0 of each subject at the time of enrollment."
            }, 
            {
                "measure": "Evaluation of the sero-prevalence of anti-pertussis antibodies among healthcare professionals by previous history of pertussis.", 
                "safety_issue": "No", 
                "time_frame": "Day 0 of each subject at the time of enrollment."
            }, 
            {
                "measure": "Description of the knowledge and beliefs about whooping cough and vaccination against pertussis among healthcare professionals.", 
                "safety_issue": "No", 
                "time_frame": "Day 0 of each subject at the time of enrollment."
            }, 
            {
                "measure": "Description of the household composition of healthcare professionals to identify the proportion of healthcare professionals potentially at a higher risk of contracting and transmitting pertussis.", 
                "safety_issue": "No", 
                "time_frame": "Day 0 of each subject at the time of enrollment."
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}